Celldex Therapeutics shares owned by Capstone Investment Advisors
Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Capstone Investment Advisors
from 13F filings
Historical chart of Capstone Investment Advisors investment in Celldex Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Celldex Therapeutics held by Capstone Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Celldex Therapeutics by Capstone Investment Advisors
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-03-31 | $800k | 19k | 41.97 |
2023-12-31 | $502k | 13k | 39.66 |
2020-12-31 | $470k | 27k | 17.52 |
More positions owned by Capstone Investment Advisors
View all positions for Capstone Investment Advisors